Novartis' Top Japan Executives Quit over Cancer Drug Scandal

Japanese unit hid serious potential side effects of leukemia treatments from regulators. read more
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.